Home > SITE MAP
SITE MAP
News items
- GMP agreement for Sr-82
- Radioisotopes productions
- Gen2Bio 2013
- Full power irradiation at Arronax
- Production of Strontium-82
- First production of strontium-82
news
- Jacques BARBET has been appointed as director of the ARRONAX GIP
- The Equipment of Excellence ArronaxPlus
- Arronax cyclotron inauguration
- Educational action around Arronax cyclotron
- A postgraduate education session of the French Society of Radiopharmacy at Arronax
- Appointment of Jacques Barbet as director
- Nuclear Technologies for Health Symposium in NANTES
- Workshop on Innovative Personalized Radioimmunotherapy (WIPR)
- New website http://www.cyclotron-nantes.fr
- 8th Thematic workshop of the Tumor Targeting & Radiotherapies network of the Cancéropôle Grand Oues
Production of radioactive isotopes
Scientific publications
R&D
Astate-211
Copper-64
Germanium-68
Strontium-82
History
The Arronax facility
PIXE / PIGE
Accelerator
Laboratories
Radiobiology
Physics
Partnership
Publications
about us
Arronax
R&D
Radionuclides production
8 questions on ARRONAX
- What is ARRONAX?
- Where is ARRONAX?
- What is the objective of ARRONAX?
- What are the domains of applications?
- Is ARRONAX similar to the other cyclotrons?
- Could ARRONAX be dangerous?
- How many cyclotrons are used in Europe for medical purposes ?
- Who will use ARRONAX?
Arronax GIP
Chemistry and radiopharmaceticals
Subatech
Socio economic impact
Members
Mission
Scienfitic Board
our facility
Preclinical assessment and clinical trials
CRCNA
Productions
Nuclear Medicine Department CHU Nantes/ICO
Inert and living matter under irradiation
R and D
Ceisam
Education
Partnership
CEMA Oniris
Videos
Pictures
- PHOTOS
- 2006, 2007 - Progress of ARRONAX building site
- 2007- Progress of ARRONAX building site
- 2008 - Progress of ARRONAX Machine
